Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Children's cancers, Leukaemia
Results
Phase 1/2
This trial looked at decitabine followed by cytarabine for acute myeloid leukaemia (AML). It was for children and teenagers whose AML had come back or treatment had stopped working.
This trial was open for people to join between 2014 and 2016. The team published the results in 2019.
Recruitment start: 10 January 2014
Recruitment end: 30 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Pam Kearns
Janssen-Cilag International NV
NIHR Clinical Research Network: Cancer
Last reviewed: 13 January 2022
CRUK internal database number: 11323
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
